NCT00004419View on ClinicalTrials.gov

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

September 30, 2000

Conditions
Insulin ResistanceHyperglycemia
Interventions
DRUG

insulin-like growth factor I

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT00004419 - Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance | Biotech Hunter | Biotech Hunter